chr8-124488610-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3

The NM_032026.4(TATDN1):​c.878T>C​(p.Phe293Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000341 in 1,554,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )

Consequence

TATDN1
NM_032026.4 missense

Scores

11
5
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.33

Publications

0 publications found
Variant links:
Genes affected
TATDN1 (HGNC:24220): (TatD DNase domain containing 1) Predicted to enable 3'-5'-exodeoxyribonuclease activity. Predicted to be involved in DNA metabolic process and nucleic acid phosphodiester bond hydrolysis. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
RNF139 (HGNC:17023): (ring finger protein 139) The protein encoded by this gene is a multi-membrane spanning protein containing a RING-H2 finger. This protein is located in the endoplasmic reticulum, and has been shown to possess ubiquitin ligase activity. This gene was found to be interrupted by a t(3:8) translocation in a family with hereditary renal and non-medulary thyroid cancer. Studies of the Drosophila counterpart suggested that this protein may interact with tumor suppressor protein VHL, as well as with COPS5/JAB1, a protein responsible for the degradation of tumor suppressor CDKN1B/P27KIP. [provided by RefSeq, Jul 2008]
RNF139 Gene-Disease associations (from GenCC):
  • nonpapillary renal cell carcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.797

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TATDN1NM_032026.4 linkc.878T>C p.Phe293Ser missense_variant Exon 12 of 12 ENST00000276692.11 NP_114415.1 Q6P1N9-1
RNF139NM_007218.4 linkc.*966A>G 3_prime_UTR_variant Exon 2 of 2 ENST00000303545.4 NP_009149.2 Q8WU17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TATDN1ENST00000276692.11 linkc.878T>C p.Phe293Ser missense_variant Exon 12 of 12 1 NM_032026.4 ENSP00000276692.6 Q6P1N9-1
RNF139ENST00000303545.4 linkc.*966A>G 3_prime_UTR_variant Exon 2 of 2 1 NM_007218.4 ENSP00000304051.4 Q8WU17

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152202
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000785
AC:
19
AN:
242172
AF XY:
0.0000611
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000125
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000135
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000285
AC:
40
AN:
1402356
Hom.:
0
Cov.:
23
AF XY:
0.0000243
AC XY:
17
AN XY:
700210
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32150
American (AMR)
AF:
0.000118
AC:
5
AN:
42220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25614
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81580
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53308
Middle Eastern (MID)
AF:
0.000378
AC:
2
AN:
5298
European-Non Finnish (NFE)
AF:
0.0000291
AC:
31
AN:
1064694
Other (OTH)
AF:
0.0000343
AC:
2
AN:
58314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.0000807
AC XY:
6
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41444
American (AMR)
AF:
0.000523
AC:
8
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000982
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.0000742
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 08, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.878T>C (p.F293S) alteration is located in exon 12 (coding exon 12) of the TATDN1 gene. This alteration results from a T to C substitution at nucleotide position 878, causing the phenylalanine (F) at amino acid position 293 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T;T;.
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D;D;D
M_CAP
Benign
0.078
D
MetaRNN
Pathogenic
0.80
D;D;D
MetaSVM
Uncertain
0.43
D
MutationAssessor
Pathogenic
4.6
.;H;.
PhyloP100
6.3
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-7.0
.;D;D
REVEL
Uncertain
0.51
Sift
Pathogenic
0.0
.;D;D
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
.;D;.
Vest4
0.74
MVP
0.47
MPC
0.080
ClinPred
1.0
D
GERP RS
4.3
Varity_R
0.99
gMVP
0.82
Mutation Taster
=11/89
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369341160; hg19: chr8-125500851; API